Reuters logo
4 months ago
BRIEF-Celldex Q4 revenue $1.9 million versus $5.5 million
March 14, 2017 / 9:08 PM / 4 months ago

BRIEF-Celldex Q4 revenue $1.9 million versus $5.5 million

2 Min Read

March 14 (Reuters) - Celldex Therapeutics Inc

* Celldex provides corporate update and reports full year 2016 results

* Q4 loss per share $0.30

* Q4 revenue $1.9 million versus $5.5 million

* Q4 revenue view $1.1 million -- Thomson Reuters I/B/E/S

* Q4 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S

* Celldex therapeutics - cash, cash equivalents and marketable securities as of dec 31, 2016 were $189.8 million compared to $203.2 million as of sept 30, 2016

* Celldex therapeutics inc says chip catlin, senior vice president and chief financial officer, shared his intention to retire in june this year

* Says sam martin, current vice president of finance will be promoted to cfo role concurrent with chip's departure

* Celldex therapeutics inc- increase in qtrly revenue was primarily due to clinical trial collaboration with bristol-myers squibb and increase in grant revenue

* Celldex therapeutics- cash,cash equivalents,marketable securities at dec 31,enough to meet estimated working capital,fund planned operations through 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below